A retrospective study testing the potential predictive value for reponse to anthracyclines of topoisomerase IIalpha evaluated in breast cancer patients by an immunofluorence quantitative method
TOP2A protein by quantitative immunofluorescence as a predictor of response to epirubicin in the neoadjuvant treatment of breast cancer / -Moretti E; Desmedt C; Biagioni C; Regan MM; Oakman C; Larsimont D; Galardi F; Piccart-Gebhart M; Sotiriou C; Rimm DL; Di Leo A. - In: FUTURE ONCOLOGY. - ISSN 1744-8301. - ELETTRONICO. - (2013), pp. 1477-1487.
TOP2A protein by quantitative immunofluorescence as a predictor of response to epirubicin in the neoadjuvant treatment of breast cancer.
MORETTI, ERICA;
2013
Abstract
A retrospective study testing the potential predictive value for reponse to anthracyclines of topoisomerase IIalpha evaluated in breast cancer patients by an immunofluorence quantitative method
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
